Auxilius
Data-driven platform, Auxilius, optimizes biotech trial costs and manages financial risks for efficient outcomes.
Founded
2020Data-driven platform, Auxilius, optimizes biotech trial costs and manages financial risks for efficient outcomes.
Auxilius, founded to revolutionize financial management in clinical trials, focuses on helping biotech companies control trial costs, manage financial risks, and optimize spending to meet trial targets. Their data-driven platform is designed specifically for the biopharma industry, providing tools for accurate forecasting, budgeting, and accrual management. Auxilius aims to integrate financial management seamlessly into the clinical trial process, ensuring that financial oversight contributes to the overall success of drug development.
Notable figures associated with Auxilius include key biopharma industry experts and investors who have recognized the platform's potential to transform clinical trial financial management. The company has achieved significant milestones, such as being trusted by leading biopharma teams and auditors for their robust financial solutions. Auxilius has made a substantial impact by enabling more efficient and effective financial oversight in clinical trials, ultimately supporting the development of new therapies and contributing to advancements in healthcare.
Companies similar to Auxilius include Auxilius Pharma, Miracle, iClinical and Algorics.
Auxilius was founded in 2020.
Auxilius' headquarters is located in New York City, NY, US.
Auxilius' most recent funding round was for $10M (USD) in June 2022.
As of Jun 16, 2022, Auxilius has disclosed funding of $10M (USD). Undisclosed round amounts are excluded.
Auxilius has 38 employees as of Feb 4, 2024.
Algorics
